Literature DB >> 31291776

Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: The ARIC study.

Renato Quispe1,2, Mohamed B Elshazly1,3, Di Zhao4, Peter P Toth1,5,6, Rishi Puri7, Salim S Virani8, Roger S Blumenthal1, Seth S Martin1, Steven R Jones1, Erin D Michos1,4.   

Abstract

AIMS: The total cholesterol (TC)/high-density lipoprotein (HDL) cholesterol ratio may carry additional information not available in more commonly used single cholesterol measures. Analysis of discordance between lipid parameters might help assess the impact of such additional information on the risk of atherosclerotic cardiovascular disease. We aimed to investigate the role of the TC/HDL-cholesterol ratio in determining atherosclerotic cardiovascular disease risk when discordant with low-density lipoprotein (LDL) cholesterol and non-HDL-cholesterol.
METHODS: We studied 14,403 Atherosclerosis Risk in Communities (ARIC) study participants who were free of atherosclerotic cardiovascular disease at baseline. TC/HDL-cholesterol discordance with LDL-cholesterol (estimated by the novel Martin/Hopkins method) and non-HDL-cholesterol was assessed at five visits and determined by being at or above the median for each lipid parameter. We constructed Cox proportional hazard models to estimate the risk for incident atherosclerotic cardiovascular disease events associated with each lipid concordance/discordance category using a time-varying approach.
RESULTS: Mean age of participants was 54.1 years, 56% women and 25% black. There were 2634 atherosclerotic cardiovascular disease events over a median (interquartile range) follow-up of 24.2 (16.0-25.4) years. Among individuals with LDL-cholesterol and non-HDL-cholesterol less than the median, 26% and 21% had discordant TC/HDL-cholesterol at or above the median, respectively. These individuals had a 24% (hazard ratio (HR) 1.24, 95% confidence interval (CI) 1.09, 1.41) and 29% (HR 1.29, 95% CI 1.13, 1.46) greater risk of incident atherosclerotic cardiovascular disease, respectively, compared to those with TC/HDL-cholesterol less than the median after multivariable adjustment. In individuals with diabetes with LDL-cholesterol or non-HDL-cholesterol less than the median, discordant TC/HDL-cholesterol at or above the median was more prevalent at 48% and 38%, respectively.
CONCLUSION: Clinically significant discordance exists between TC/HDL-cholesterol, available from the standard lipid profile, and the routinely used non-HDL-cholesterol and LDL-cholesterol. Such discordance may help inform atherosclerotic cardiovascular disease risk management, particularly in individuals with diabetes in whom discordance is more common.

Entities:  

Keywords:  HDL-cholesterol; LDL-cholesterol; Total cholesterol; cardiovascular risk; non-HDL-cholesterol; primary prevention

Year:  2019        PMID: 31291776      PMCID: PMC6952589          DOI: 10.1177/2047487319862401

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  30 in total

1.  Implications of Total to High-Density Lipoprotein Cholesterol Ratio Discordance With Alternative Lipid Parameters for Coronary Atheroma Progression and Cardiovascular Events.

Authors:  Mohamed B Elshazly; Stephen J Nicholls; Steven E Nissen; Julie St John; Seth S Martin; Steven R Jones; Renato Quispe; Brian Stegman; Samir R Kapadia; E Murat Tuzcu; Rishi Puri
Journal:  Am J Cardiol       Date:  2016-06-15       Impact factor: 2.778

2.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Scott M Grundy; Neil J Stone; Alison L Bailey; Craig Beam; Kim K Birtcher; Roger S Blumenthal; Lynne T Braun; Sarah de Ferranti; Joseph Faiella-Tommasino; Daniel E Forman; Ronald Goldberg; Paul A Heidenreich; Mark A Hlatky; Daniel W Jones; Donald Lloyd-Jones; Nuria Lopez-Pajares; Chiadi E Ndumele; Carl E Orringer; Carmen A Peralta; Joseph J Saseen; Sidney C Smith; Laurence Sperling; Salim S Virani; Joseph Yeboah
Journal:  J Am Coll Cardiol       Date:  2018-11-10       Impact factor: 24.094

3.  National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary.

Authors:  Terry A Jacobson; Matthew K Ito; Kevin C Maki; Carl E Orringer; Harold E Bays; Peter H Jones; James M McKenney; Scott M Grundy; Edward A Gill; Robert A Wild; Don P Wilson; W Virgil Brown
Journal:  J Clin Lipidol       Date:  2014-07-15       Impact factor: 4.766

4.  Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience.

Authors:  A D White; A R Folsom; L E Chambless; A R Sharret; K Yang; D Conwill; M Higgins; O D Williams; H A Tyroler
Journal:  J Clin Epidemiol       Date:  1996-02       Impact factor: 6.437

Review 5.  Triglycerides to high-density lipoprotein-cholesterol ratio, glycemic control and cardiovascular risk in obese patients with type 2 diabetes.

Authors:  Renato Quispe; Seth S Martin; Steven R Jones
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-04       Impact factor: 3.243

6.  Discordance analysis of apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study.

Authors:  Allan D Sniderman; Shofique Islam; Salim Yusuf; Matthew J McQueen
Journal:  Atherosclerosis       Date:  2012-09-23       Impact factor: 5.162

7.  Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events.

Authors:  Samia Mora; Julie E Buring; Paul M Ridker
Journal:  Circulation       Date:  2013-12-17       Impact factor: 29.690

8.  Are we moving towards concordance on the principle that lipid discordance matters?

Authors:  Seth S Martin; Erin D Michos
Journal:  Circulation       Date:  2013-12-17       Impact factor: 29.690

9.  Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.

Authors:  Erik Ingelsson; Ernst J Schaefer; John H Contois; Judith R McNamara; Lisa Sullivan; Michelle J Keyes; Michael J Pencina; Christopher Schoonmaker; Peter W F Wilson; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  JAMA       Date:  2007-08-15       Impact factor: 56.272

10.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

View more
  12 in total

1.  Association of lowering apolipoprotein B with cardiovascular outcomes across various lipid-lowering therapies: Systematic review and meta-analysis of trials.

Authors:  Safi U Khan; Muhammad U Khan; Shahul Valavoor; Muhammad Shahzeb Khan; Victor Okunrintemi; Mamas A Mamas; Thorsten M Leucker; Michael J Blaha; Erin D Michos
Journal:  Eur J Prev Cardiol       Date:  2019-09-02       Impact factor: 7.804

2.  Association Between Lipids and Arterial Stiffness for Primary Cardiovascular Prevention in a General Middle-Aged European Population.

Authors:  Alexandre Vallée
Journal:  Front Cardiovasc Med       Date:  2022-05-27

3.  Serum concentration of asprosin in new-onset type 2 diabetes.

Authors:  Shakiba Naiemian; Mohsen Naeemipour; Mehdi Zarei; Moslem Lari Najafi; Ali Gohari; Mohammad Reza Behroozikhah; Hafez Heydari; Mohammad Miri
Journal:  Diabetol Metab Syndr       Date:  2020-07-23       Impact factor: 3.320

4.  Total cholesterol/HDL-C ratio versus non-HDL-C as predictors for ischemic heart disease: a 17-year follow-up study of women in southern Sweden.

Authors:  Susanna Calling; Sven-Erik Johansson; Moa Wolff; Jan Sundquist; Kristina Sundquist
Journal:  BMC Cardiovasc Disord       Date:  2021-04-05       Impact factor: 2.298

5.  Proteomic and Structural Manifestations of Cardiomyopathy in Rat Models of Obesity and Weight Loss.

Authors:  Arkadiusz D Liśkiewicz; Łukasz Marczak; Katarzyna Bogus; Daniela Liśkiewicz; Marta Przybyła; Joanna Lewin-Kowalik
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-24       Impact factor: 6.055

6.  Profile of cardiovascular disease risk in type 2 diabetes mellitus patients receiving statin therapy: A cross-sectional study.

Authors:  Yasmin Karimah Ikhsan; Soebagijo Adi Soelistijo; Johanes Nugroho Eko Putranto
Journal:  Ann Med Surg (Lond)       Date:  2022-02-15

7.  Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study.

Authors:  Renato Quispe; Seth Shay Martin; Erin Donelly Michos; Isha Lamba; Roger Scott Blumenthal; Anum Saeed; Joao Lima; Rishi Puri; Sarah Nomura; Michael Tsai; John Wilkins; Christie Mitchell Ballantyne; Stephen Nicholls; Steven Richard Jones; Mohamed Badreldin Elshazly
Journal:  Eur Heart J       Date:  2021-11-07       Impact factor: 35.855

8.  Association of PCSK9 plasma levels with metabolic patterns and coronary atherosclerosis in patients with stable angina.

Authors:  Chiara Caselli; Serena Del Turco; Rosetta Ragusa; Valentina Lorenzoni; Michiel De Graaf; Giuseppina Basta; Arthur Scholte; Raffaele De Caterina; Danilo Neglia
Journal:  Cardiovasc Diabetol       Date:  2019-10-31       Impact factor: 9.951

9.  High-Sensitivity C-Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study.

Authors:  Renato Quispe; Erin D Michos; Seth S Martin; Rishi Puri; Peter P Toth; Jassim Al Suwaidi; Maciej Banach; Salim S Virani; Roger S Blumenthal; Steven R Jones; Mohamed B Elshazly
Journal:  J Am Heart Assoc       Date:  2020-01-30       Impact factor: 5.501

Review 10.  HDL Dysfunctionality: Clinical Relevance of Quality Rather Than Quantity.

Authors:  Arianna Bonizzi; Gabriele Piuri; Fabio Corsi; Roberta Cazzola; Serena Mazzucchelli
Journal:  Biomedicines       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.